The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial

61Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In a randomized controlled trial involving patients with heart failure with reduced ejection fraction, treatment with Qiliqiangxin, a traditional Chinese medicine derived from 11 types of plants, decreased the incidence of cardiac events, as compared to placebo.

Cite

CITATION STYLE

APA

Cheang, I., Yao, W., Zhou, Y., Zhu, X., Ni, G., Lu, X., … Li, X. (2024). The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial. Nature Medicine, 30(8), 2295–2302. https://doi.org/10.1038/s41591-024-03169-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free